GERSHOWITZ DIANE M sold $1.4M of MCS (indirect holdings)
GERSHOWITZ DIANE M sold 50,000 indirectly-held shares of MARCUS CORP (MCS) at $27.61 ($1.38M total) on 2026-09-23.
MARCUS CORP
No enriched coverage for $MCS in the last 7 days.
GERSHOWITZ DIANE M sold 50,000 indirectly-held shares of MARCUS CORP (MCS) at $27.61 ($1.38M total) on 2026-09-23.
AMC and Marcus (MCS) report Q2 2026 earnings growth, with AMC showing 14.2% revenue increase and MCS up 16.6% in theater admissions. AMC's adjusted EBITDA rose 70% to $321.4M, while MCS's theater-adjusted EBITDA increased 37% to $36.3M. MCS has lower leverage (1.1x) and stronger free cash flow, while AMC's recovery hinges on box office growth. Analysts favor MCS for its diversified earnings and higher estimate revisions.
Marcus Corp. (MCS) reported Q2 results with net earnings up 116.4% to $15.84M, or $0.51/share, and operating income rising to $27.07M from $13.01M. Adjusted EBITDA increased 43% to $46.2M. Total revenue grew 12.5% to $231.74M. Shares were up about 8.7% at $27.14, per NYSE.
Recent MCS coverage spans financial news, earnings and insider activity.
In the last 30 days, MCS insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($1.4M). The most active reporter was GERSHOWITZ DIANE M with 1 filing.
A modest insider sell by a 10% owner may signal slight negative sentiment but size is not material.
Robust earnings and low leverage could attract investors.
Q2 earnings and revenue beat with strong theater and hotel outperformance, supporting near-term upside bias and momentum trading.
The 8-K discloses a strong quarter across both segments (Theatres and Hotels & Resorts), supporting a bullish near-term earnings narrative.
Re-rating of regional exhibition demand is the key driver, with updated Q2 revenue expectations.
AlphAI scores every news story that mentions MCS with an AI model for sentiment and relevance, and aggregates insider trades from MARCUS CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
GERSHOWITZ DIANE M sold 50,000 indirectly-held shares of MARCUS CORP (MCS) at $27.61 ($1.38M total) on 2026-09-23.
1 min readAMC and Marcus (MCS) report Q2 2026 earnings growth, with AMC showing 14.2% revenue increase and MCS up 16.6% in theater admissions. AMC's adjusted EBITDA rose 70% to $321.4M, while MCS's theater-adjusted EBITDA increased 37% to $36.3M. MCS has lower leverage (1.1x) and stronger free cash flow, while AMC's recovery hinges on box office growth. Analysts favor MCS for its diversified earnings and higher estimate revisions.
3 min readMarcus Corp. (MCS) reported Q2 results with net earnings up 116.4% to $15.84M, or $0.51/share, and operating income rising to $27.07M from $13.01M. Adjusted EBITDA increased 43% to $46.2M. Total revenue grew 12.5% to $231.74M. Shares were up about 8.7% at $27.14, per NYSE.
2 min readMARCUS CORP (MCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MARCUS CORPORATION REPORTS SECOND QUARTER FISCAL 2026 RESULTS Marcus Corporation reports strong net earnings and highest revenue and Adjusted EBITDA in a second quarter since the pandemic; Marcus Theatres and Marcus Hotels & Resorts outperformed their respective indu
4 min readChristopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.
6 min readExecutives from Marcus Corp. argue that a study recommending a new Milwaukee convention center hotel is flawed. They contend that the proposed hotel would require public financing and negatively impact existing downtown hotels, stating that Milwaukee's hotel market is not currently healthy.
2 min readImage source: The Motley Fool.Friday, Oct. 31, 2025, at 11 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
3 min readMarcus (MCS) delivered earnings and revenue surprises of -2.33% and +0.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2 min readMarcus (MCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 min readMarcus (MCS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 min read